Park Edge Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Park Edge Advisors's MRK Position: Q3 2026 in Review
Park Edge Advisors reduced its Merck (MRK) stake by 4.1% in Q3 2026, selling an estimated $24.9K and leaving 4,198 shares worth $610K. The position accounts for 0.13% of the portfolio, ranked #96.
Park Edge Advisors first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.31M in Q4 2023. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Park Edge Advisors held 4,198 shares of Merck worth $610K as of Q3 2026.
- Park Edge Advisors sold 180 Merck shares in Q3 2026, an estimated $24.9K.
- Merck made up 0.13% of Park Edge Advisors's portfolio in Q3 2026, its #96 holding.
- Park Edge Advisors first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
- Park Edge Advisors's Merck position peaked at $1.31M in Q4 2023.
- 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Park Edge Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.